Recently, a new definition of NAFLD was suggested by a panel of international experts: Metabolic Associated Fatty Liver Disease (MAFLD), which contains positive criteria and is independent of alcohol use to diagnose the disease [1]
In addition, 87 showed activity against lipoxygenase, DPPH and FRAP, and in all cases was the best evaluated compound, even when compared to positive controls
& Jakobkiewicz-Banecka, J
it is recruiting 1,800 participants with type 2 diabetes Clinical Trials Identifier: NCT030495102 Trial name: A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants with Type 2 Diabetes (AWARD-11) Diabetes type: Type 2 What the trial is testing: This study will test the effectiveness of different doses of Trulicity (dulaglutide), a GLP-1 agonist, in addition to metformin for type 2 diabetes
Reduced systemic inflammation may lower the inflammatory tone in the brain
Low mood